Brief: Geneuro Cash Position At December 31 Of 5.9 Million Euros

Geneuro SA

30/01/2020 17:39

Jan 30 (Reuters) - Geneuro SA  GNRO.PA :
    * CASH POSITION OF EUR 5.9 MILLION AT DECEMBER 31, 2019
    * BROADENING PIPELINE THROUGH ONGOING PRECLINICAL
DEVELOPMENT OF A
NEW ANTIBODY AGAINST AMYOTROPHIC LATERAL SCLEROSIS, AIMING TO
START CLINICAL STUDIES IN 2021
    * NEW CLINICAL TRIAL OF TEMELIMAB IN MULTIPLE SCLEROSIS (MS)
WITH
KAROLINSKA INSTITUTET / ACADEMIC SPECIALIST CENTER OF STOCKHOLM
TO START IN Q1 2020
    * OUR CASH BALANCE AT YEAR-END 2019 COVERS OUR NEEDS INTO Q4
2020
- CEO
    * WE WILL SHORTLY LAUNCH CAPITAL INCREASE TO SECURE
ADDITIONAL
RESOURCES TO EXTEND OUR RUNWAY - CEO

Source text for Eikon:  ID:nBw2Z3yHfa 
Further company coverage:  GNRO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))